Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sequential Therapy vs Standard IV for MSSA Bacteremia
NCT01875263Phase 3Terminated
- Sponsor
- Andalusian Progress and Health Public Foundation
- Start
- May 2013
- Primary completion
- Nov 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of levofloxacin in Bacteremia, sponsored by Andalusian Progress and Health Public Foundation. Started May 2013; status: terminated.
02
Drugs
levofloxacin
03
Conditions
Bacteremia
Beyond the preview
Go deeper on NCT01875263.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01875263.